Thank you very much for seeing the official site of Novumcella Inc.  “Novumcella” was named from the Latin innovation cell, Novum Cella.

The Company intends to administer intravenous injections of adipocyte-derived stem cells and statin PLGA nanoparticles conjugates to a patient to treat systemic sclerosis, ulcerative colitis, interstitial pneumonia, osteoarthritis and so on.  We are aiming to be a leading global regenerative medicine company that treats refractory diseases that do not cure with existing medical treatment. We also develop CRO business by a management team with superior experiences of consultation on pharmaceutical affairs.

We will do our utmost to contribute to the healthy and bright future of customers.